Maternal perinatal depressive symptoms and offspring psychotic experiences at 18 years of age: a longitudinal study.


Journal

The lancet. Psychiatry
ISSN: 2215-0374
Titre abrégé: Lancet Psychiatry
Pays: England
ID NLM: 101638123

Informations de publication

Date de publication:
05 2020
Historique:
received: 07 01 2020
revised: 06 03 2020
accepted: 16 03 2020
entrez: 1 5 2020
pubmed: 1 5 2020
medline: 2 7 2020
Statut: ppublish

Résumé

Evidence exists that maternal depression in the perinatal period has an adverse effect on a range of early childhood outcomes and increases the risk of offspring depression during adolescence. However, the association between maternal depression during the perinatal period and offspring psychotic experiences has not been investigated. We aimed to investigate whether there is an association between maternal antenatal or postnatal depression and offspring psychotic experiences at 18 years of age. This longitudinal study used data from the Avon Longitudinal Study of Parents and Children (ALSPAC), a prospective birth cohort, which recruited 14 541 pregnant women with an estimated delivery date between April 1, 1991, and Dec 31, 1992. Perinatal depression was measured using the Edinburgh Postnatal Depression Scale (EPDS); offspring psychotic experiences at 18 years of age were measured using the Psychosis-Like Symptom Interview. Offspring of mothers with complete data on maternal perinatal depression measures, and complete data on outcome (psychotic experiences) and confounding variables were included in the main analysis. For the main analysis, we used logistic regression to examine the associations between maternal depression (antenatal and postnatal) and offspring psychotic experiences at the age of 18 years. We used biprobit regression to model the association between maternal antenatal depression and the two offspring outcomes (psychotic experiences and depression) at 18 years of age jointly. 3067 offspring for whom data were available on maternal perinatal depression and offspring psychotic experiences aged 18 years were included in analyses. Maternal antenatal depressive symptoms were associated with offspring psychotic experiences at 18 years of age, with an unadjusted odds ratio (OR) of 1·38 (95% CI 1·18-1·61, p=0·0001) and after adjustment for confounders, an OR of 1·26 (1·06-1·49, p=0·0074). Maternal antenatal depressive symptoms were associated with both offspring psychotic experiences at the age of 18 years (n=2830, OR for a 5-point increase in EPDS score: 1·32 [95% CI 1·16-1·51], p<0·0001) and offspring depression at 18 years (OR for a 5-point increase in EPDS score: 1·18 [1·03-1·34], p=0·016). From joint modelling, there was no evidence that the association between maternal antenatal depression and offspring psychotic experiences differed in strength compared with offspring depression (p=0·19). The offspring of mothers who experience depression in the perinatal period are more likely to report psychotic experiences at 18 years of age. If the association is found to be causal, it would strengthen the case for identifying and treating maternal depression during and after pregnancy. UK Medical Research Council and the Wellcome Trust.

Sections du résumé

BACKGROUND
Evidence exists that maternal depression in the perinatal period has an adverse effect on a range of early childhood outcomes and increases the risk of offspring depression during adolescence. However, the association between maternal depression during the perinatal period and offspring psychotic experiences has not been investigated. We aimed to investigate whether there is an association between maternal antenatal or postnatal depression and offspring psychotic experiences at 18 years of age.
METHODS
This longitudinal study used data from the Avon Longitudinal Study of Parents and Children (ALSPAC), a prospective birth cohort, which recruited 14 541 pregnant women with an estimated delivery date between April 1, 1991, and Dec 31, 1992. Perinatal depression was measured using the Edinburgh Postnatal Depression Scale (EPDS); offspring psychotic experiences at 18 years of age were measured using the Psychosis-Like Symptom Interview. Offspring of mothers with complete data on maternal perinatal depression measures, and complete data on outcome (psychotic experiences) and confounding variables were included in the main analysis. For the main analysis, we used logistic regression to examine the associations between maternal depression (antenatal and postnatal) and offspring psychotic experiences at the age of 18 years. We used biprobit regression to model the association between maternal antenatal depression and the two offspring outcomes (psychotic experiences and depression) at 18 years of age jointly.
FINDINGS
3067 offspring for whom data were available on maternal perinatal depression and offspring psychotic experiences aged 18 years were included in analyses. Maternal antenatal depressive symptoms were associated with offspring psychotic experiences at 18 years of age, with an unadjusted odds ratio (OR) of 1·38 (95% CI 1·18-1·61, p=0·0001) and after adjustment for confounders, an OR of 1·26 (1·06-1·49, p=0·0074). Maternal antenatal depressive symptoms were associated with both offspring psychotic experiences at the age of 18 years (n=2830, OR for a 5-point increase in EPDS score: 1·32 [95% CI 1·16-1·51], p<0·0001) and offspring depression at 18 years (OR for a 5-point increase in EPDS score: 1·18 [1·03-1·34], p=0·016). From joint modelling, there was no evidence that the association between maternal antenatal depression and offspring psychotic experiences differed in strength compared with offspring depression (p=0·19).
INTERPRETATION
The offspring of mothers who experience depression in the perinatal period are more likely to report psychotic experiences at 18 years of age. If the association is found to be causal, it would strengthen the case for identifying and treating maternal depression during and after pregnancy.
FUNDING
UK Medical Research Council and the Wellcome Trust.

Identifiants

pubmed: 32353278
pii: S2215-0366(20)30132-2
doi: 10.1016/S2215-0366(20)30132-2
pmc: PMC7606907
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

431-440

Subventions

Organisme : Wellcome Trust
ID : 084268/Z/07/Z
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_PC_19009
Pays : United Kingdom
Organisme : Medical Research Council
ID : G0701503/85179
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 211163/Z/18/Z
Pays : United Kingdom
Organisme : Medical Research Council
ID : G9815508
Pays : United Kingdom
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 102215/2/13/2
Pays : United Kingdom
Organisme : Medical Research Council
ID : G0701503
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_PC_15018
Pays : United Kingdom

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved.

Références

Psychol Med. 2014 Sep;44(12):2557-66
pubmed: 25055173
Am J Psychiatry. 2010 Jan;167(1):70-7
pubmed: 19833791
Schizophr Bull. 1996;22(3):511-20
pubmed: 8873301
Eur Child Adolesc Psychiatry. 2008 Feb;17(1):9-19
pubmed: 18188662
Psychol Med. 1992 May;22(2):465-86
pubmed: 1615114
Psychoneuroendocrinology. 2019 Nov;109:104383
pubmed: 31400561
Neurosci Biobehav Rev. 2017 Jul 28;:
pubmed: 28757456
Psychol Med. 2003 Feb;33(2):307-18
pubmed: 12622309
Schizophr Res. 2018 Jul;197:428-433
pubmed: 29510927
Schizophr Bull. 2016 Jan;42(1):125-33
pubmed: 26303935
World Psychiatry. 2016 Jun;15(2):118-24
pubmed: 27265696
J Affect Disord. 2019 Apr 15;249:63-72
pubmed: 30759404
Am J Psychiatry. 2013 Jul;170(7):742-50
pubmed: 23639948
Int J Epidemiol. 2013 Feb;42(1):111-27
pubmed: 22507743
Soc Psychiatry Psychiatr Epidemiol. 2015 Jul;50(7):1017-27
pubmed: 26002411
JAMA Netw Open. 2018 Jul 6;1(3):e180725
pubmed: 30646025
Am J Psychiatry. 1998 Mar;155(3):355-64
pubmed: 9501745
Eur Psychiatry. 2017 May;42:36-43
pubmed: 28192768
JAMA Psychiatry. 2019 Dec 1;76(12):1256-1265
pubmed: 31553412
Int J Epidemiol. 2013 Feb;42(1):97-110
pubmed: 22507742
Soc Psychiatry Psychiatr Epidemiol. 1999 Mar;34(3):166-72
pubmed: 10327843
BMJ. 2009 Jun 29;338:b2393
pubmed: 19564179
Lancet. 2014 Nov 15;384(9956):1800-19
pubmed: 25455250
Int J Epidemiol. 2013 Aug;42(4):1012-4
pubmed: 24062287
Psychol Med. 2011 Jan;41(1):1-6
pubmed: 20624328
Psychopharmacology (Berl). 2011 Mar;214(1):89-106
pubmed: 20949351
Lancet. 2014 May 10;383(9929):1677-1687
pubmed: 24315522
Arch Womens Ment Health. 2017 Feb;20(1):39-48
pubmed: 27699637
Br J Psychiatry. 1987 Jun;150:782-6
pubmed: 3651732
JAMA Psychiatry. 2013 Dec;70(12):1312-9
pubmed: 24108418
Br J Psychiatry. 2015 Sep;207(3):213-20
pubmed: 26045352
BMJ. 1994 Jun 4;308(6942):1499
pubmed: 8019287
Arch Womens Ment Health. 2015 Apr;18(2):187-195
pubmed: 25088531
Br J Psychiatry. 2009 Sep;195(3):249-56
pubmed: 19721116

Auteurs

Ramya Srinivasan (R)

Division of Psychiatry, Faculty of Brain Sciences, University College London, London, UK. Electronic address: ramya.srinivasan.12@ucl.ac.uk.

Rebecca M Pearson (RM)

Population Health Sciences, University of Bristol, Bristol, UK.

Sonia Johnson (S)

Division of Psychiatry, Faculty of Brain Sciences, University College London, London, UK.

Gemma Lewis (G)

Division of Psychiatry, Faculty of Brain Sciences, University College London, London, UK.

Glyn Lewis (G)

Division of Psychiatry, Faculty of Brain Sciences, University College London, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH